Ernexa Therapeutics (ERNAW) EPS (Diluted) (2010 - 2026)
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) EPS (Diluted) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - | 0.15 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Ernexa Therapeutics | 49,449.40 | 49,449.40 | - | -3.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.40 |
| Mar 31, 2026 | -6.95 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.15 |
| Jun 30, 2025 | -0.61 |
| Mar 31, 2025 | -2.31 |
| Dec 31, 2024 | -6.34 |
| Sep 30, 2024 | -73.76 |
| Jun 30, 2024 | -15.35 |
| Mar 31, 2024 | -18.43 |
| Dec 31, 2023 | -17.39 |
| Sep 30, 2023 | -15.50 |
| Jun 30, 2023 | -12.77 |
| Mar 31, 2023 | -15.84 |
| Dec 31, 2022 | -22.11 |
| Sep 30, 2022 | -37.31 |
| Jun 30, 2022 | -17.38 |
| Mar 31, 2022 | -52.45 |
| Dec 31, 2021 | -55.14 |
| Sep 30, 2021 | -510.34 |